OVA-E1 peptide contains a defined sequence of polar, aromatic, and charged residues that promote diverse secondary-structure motifs. Researchers use it to examine antigenic determinants, peptide folding dynamics, and residue-specific interactions. The sequence's balanced polarity aids studies of conformational transitions. Its architecture supports detailed biophysical profiling.
CAT No: R2407
CAS No:153316-01-9
Synonyms/Alias:OVA-E1 peptide;153316-01-9;(2S,5S,8S,11S,14S,17S,20S,23S)-23-Amino-14-(2-amino-2-oxoethyl)-5-(4-aminobutyl)-11-benzyl-17,20-di((S)-sec-butyl)-8-(2-carboxyethyl)-2-isobutyl-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazahexacosanedioic acid;HY-P2319;AKOS040756882;DA-76497;CS-0129511;(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S,3S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid;
OVA-E1 peptide is a synthetic peptide derived from the ovalbumin protein, widely recognized for its utility in immunological and biochemical research. As a well-defined epitope, OVA-E1 peptide exhibits high specificity in binding interactions, making it an invaluable tool for scientists investigating antigen-antibody responses, T-cell activation, and epitope mapping. Its stable structure and reproducible synthesis ensure consistent experimental outcomes, facilitating its integration into a variety of laboratory protocols. The peptide's compatibility with both in vitro and in vivo systems further broadens its research applications, allowing for detailed exploration of immune mechanisms and signaling pathways.
Immunological research: OVA-E1 peptide serves as a model antigen in immunological studies, particularly in the characterization of T-cell responses. Researchers employ this peptide to stimulate specific T-cell populations, enabling the detailed analysis of antigen presentation and recognition processes. By providing a controlled and reproducible stimulus, it allows for the dissection of cellular and molecular events underlying immune activation, tolerance, and memory formation, thereby advancing the understanding of adaptive immunity.
Vaccine development studies: In the context of vaccine research, the OVA-E1 epitope is frequently used to evaluate adjuvant efficacy and immunogenicity. By incorporating the peptide into experimental vaccine formulations, scientists can monitor the induction of antigen-specific immune responses and assess the potential of new adjuvants or delivery systems. This approach aids in optimizing vaccine constructs and understanding the factors that enhance or modulate immunogenicity, which is critical for the rational design of next-generation vaccines.
Epitope mapping: OVA-E1 peptide is instrumental in epitope mapping experiments, where it helps identify the specific regions of antigens recognized by antibodies or T-cell receptors. Through systematic testing with overlapping or truncated peptide variants, researchers can delineate the minimal recognition sequences and structural motifs required for immune recognition. This information is essential for designing targeted immunotherapies, diagnostic reagents, and synthetic vaccines with enhanced specificity.
Allergy research: As a fragment of ovalbumin, OVA-E1 peptide is utilized in allergy studies to investigate the mechanisms of allergic sensitization and immune tolerance. By exposing immune cells to the peptide, scientists can model allergic responses in vitro, analyze cytokine production, and explore the factors that contribute to hypersensitivity or tolerance induction. These insights support the development of novel strategies for allergy prevention and immunomodulation.
Cell signaling analysis: The use of OVA-E1 in cell signaling research allows for the examination of intracellular pathways activated upon antigen recognition. By stimulating immune cells with the peptide, investigators can monitor downstream signaling events, such as phosphorylation cascades, transcription factor activation, and cytokine secretion. This enables a deeper understanding of the molecular mechanisms governing immune cell activation, differentiation, and effector function.
In summary, OVA-E1 peptide is a versatile and reliable research tool with broad applications across immunology, vaccine development, epitope mapping, allergy research, and cell signaling analysis. Its precise sequence and well-characterized properties facilitate reproducible experimentation and robust data generation. As a result, it continues to play a pivotal role in advancing scientific knowledge and supporting the development of innovative approaches in immunological research and related fields.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More